11/07/22 Zenas BioPharma, a global biopharmaceutical company committed to becoming a leader in the development and commercialization of immune-based therapies, today announced proceeds of $118 million in connection with the issuance of Series B preferred shares. In addition to Enavate Sciences, which led the Series B equity financing, new Zenas shareholders include Longitude Capital, Vivo Capital, Rock Springs Capital, Perceptive Advisors, Agent Capital, Pivotal bioVenture Partners and Superstring Capital.
![](https://tellusbv.isunderdev.com/app/themes/tellusbv/images/empty.png)
![](https://tellusbv.isunderdev.com/app/themes/tellusbv/images/empty.png)
![](https://tellusbv.isunderdev.com/app/themes/tellusbv/images/box-3.jpg)
![](https://tellusbv.isunderdev.com/app/themes/tellusbv/images/empty.png)
![](https://tellusbv.isunderdev.com/app/themes/tellusbv/images/box-5.jpg)
![](https://tellusbv.isunderdev.com/app/themes/tellusbv/images/empty.png)
![](https://tellusbv.isunderdev.com/app/themes/tellusbv/images/empty.png)
![](https://tellusbv.isunderdev.com/app/themes/tellusbv/images/empty.png)
![](https://tellusbv.isunderdev.com/app/themes/tellusbv/images/box-3.jpg)
![](https://tellusbv.isunderdev.com/app/themes/tellusbv/images/empty.png)
![](https://tellusbv.isunderdev.com/app/themes/tellusbv/images/empty.png)
![](https://tellusbv.isunderdev.com/app/themes/tellusbv/images/empty.png)
Tellus BioVentures is a biotechnology investment fund focused on early-stage innovation and company formation.
About Us![](https://tellusbv.isunderdev.com/app/themes/tellusbv/images/empty.png)
![](https://tellusbv.isunderdev.com/app/themes/tellusbv/images/empty.png)
![](https://tellusbv.isunderdev.com/app/themes/tellusbv/images/box-11.jpg)
![](https://tellusbv.isunderdev.com/app/themes/tellusbv/images/empty.png)
![](https://tellusbv.isunderdev.com/app/themes/tellusbv/images/box-5.jpg)
![](https://tellusbv.isunderdev.com/app/themes/tellusbv/images/box-3.jpg)
![](https://tellusbv.isunderdev.com/app/themes/tellusbv/images/empty.png)
![](https://tellusbv.isunderdev.com/app/themes/tellusbv/images/empty.png)
![](https://tellusbv.isunderdev.com/app/themes/tellusbv/images/empty.png)
![](https://tellusbv.isunderdev.com/app/themes/tellusbv/images/empty.png)
Tellus BioVentures is a biotechnology investment fund focused on early-stage innovation and company formation.
About Us![](https://tellusbv.isunderdev.com/app/themes/tellusbv/images/empty.png)
![](https://tellusbv.isunderdev.com/app/themes/tellusbv/images/empty.png)
![](https://tellusbv.isunderdev.com/app/themes/tellusbv/images/empty.png)
![](https://tellusbv.isunderdev.com/app/themes/tellusbv/images/empty.png)
![](https://tellusbv.isunderdev.com/app/themes/tellusbv/images/box-11.jpg)